201123-astrazeneca-mc-1127_7a76c80708b4fdfc5555fe26e448397a.JPG

  • November 23, 2020
  • 0
  • 4 Views

(FILES) In this file photo taken on September 11, 2020 A laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at the Italian biologics manufacturing facility of multinational corporation Catalent in Anagni, southeast of Rome. – British drugs group AstraZeneca and the University of Oxford on November 23, 2020 said their jointly-developed vaccine against Covid-19 has shown “an average efficacy of 70 percent” in trials. The results ranged between 62 and 90 percent efficacy depending on the vaccine dosage. (Photo by Vincenzo PINTO / AFP) (Photo by VINCENZO PINTO/AFP via Getty Images)


Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com
X